News from the Alzheimer’s Association International Conference (AAIC)

Exciting new Part the Cloud updates

A note from Mikey Hoag

Dear Friends,

I was saddened to hear about the passing of our friend and Part the Cloud supporter Tony Bennett. Tony was a champion of the cause who shared the gift of his beautiful voice to help increase visibility and awareness for the fight to end Alzheimer’s. We were honored to have him perform at the first Part the Cloud event in 2012, setting the tone for the event and performers who would share their talents with us in future years. We extend our heartfelt sympathy and gratitude to his family.

Tony Bennett performing at the 2012 Part the Cloud Gala

Tony’s passing is a heartbreaking reminder that while we have come so far in our fight, we have more work to do.

But, we are seeing hope and progress…

Thankfully, in the last month alone, we have seen historic progress in the Alzheimer’s and dementia research field. New treatments and diagnostics are rapidly becoming a reality. These watershed moments are due to your unwavering support of innovative programs like Part the Cloud – and I truly thank you from the bottom of my heart. This momentum is a testament to our tireless commitment and dedication to advancing high risk, high reward research. And our persistence is paying off.

Here is the latest in Alzheimer’s advancements, including highlights from the Alzheimer’s Association International Conference® (AAIC®):

Part the Cloud grantees Michal Schnaider Beeri, Ph.D. (left), Devangere Devanand, M.D. (second from left) and Steve Arnold, M.D. (right)

In addition, three Part the Cloud-funded researchers participated in a special panel discussion for philanthropic supporters who attended AAIC. All said they would not have been able to move their research forward if it wasn’t for the support of Part the Cloud grant funding from the Alzheimer's Association.

Steve Arnold, M.D., is a professor of neurology at Harvard Medical School and the Chair of Alzheimer's Therapeutic Sciences at Massachusetts General Hospital. In 2020 Dr. Arnold received a Part the Cloud grant for a pilot study evaluating whether a tuberculosis vaccination may impact brain inflammation in Alzheimer’s.

Davangere Devanand, M.D., is the co-founder of the Memory Disorders Center at Columbia University Medical Center, where he is a professor of Psychiatry and Neurology. He is also an attending psychiatrist at the New York State Psychiatric Institute and New York Presbyterian Medical Center. In 2020, Dr. Devanand received a Part the Cloud grant for his research study on antiviral treatment in mild cognitive impairment.

Michal Schnaider Beeri, Ph.D., directs the Herbert and Jacqueline Kriegers Klein Alzheimer’s Research Center at Rutgers University Medical School. In 2020 Dr. Schnaider-Beeri received a Part the Cloud grant to support a clinical trial evaluating the safety, tolerability and dose of the dual administration of insulin and another diabetes medication in individuals at risk for dementia.

Where we have come today from where we started more than a decade ago is beyond my wildest dreams. Together, we continue to make a difference in getting therapies to people sooner. I am incredibly grateful for your continued support because there is still so much more to be done. It isn't only scientists who are leading the way to a cure; your support is helping push research forward, too.

Together, we will Part the Cloud.

Mikey Hoag

Mikey Hoag
Founder, Part the Cloud


To fund Alzheimer's research with the highest probability of slowing, stopping or ultimately curing Alzheimer's disease.